|Articles|June 15, 2004
Nidek's hyperopia algorithm tops FDA criteria
Fremont, CA-The FDA has given the go-ahead to an expansion of Nidek Inc.'s hyperopia study using new software for its U.S. EC-5000 platform.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
Cataract and refractive surgery: Trends, challenges, and innovations
4
What if? Ophthalmology without OCT – Part 3
5














































.png)


